Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06410950Completed

Mechanical Muscle Proprieties in Patient with COPD

Role: lead

NCT06592742Not ApplicableCompleted

Progressive Muscle Relaxation in Pulmonary Rehab for Quality of Life, Mental Health, and Sleep in Cystic Fibrosis

Role: lead

NCT06492577Not ApplicableCompleted

Combined Pulmonary Rehabilitation and PMR for Long-Term COVID-19 Symptoms: A RCT

Role: lead

NCT06395311Completed

Psychological Distress in Patients With COPD

Role: lead

All 4 trials loaded